Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Tuesday.
Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) fell sharply in today's pre-market trading as the company announced its collaboration and license agreement with Pfizer on giroctocogene fitelparvovec will terminate effective April 21, 2025.
Sangamo Therapeutics shares dipped 50% to $1.17 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
Now Read This: